These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5720699)

  • 1. [Prophylactic therapy of patients with hemophilia A].
    Blombäck M
    Lakartidningen; 1968 Mar; 65(10):1029-30. PubMed ID: 5720699
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
    Lange D; Lazerson J
    Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
    [No Abstract]   [Full Text] [Related]  

  • 3. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia.
    Thornburg CD; Pipe SW
    Haemophilia; 2006 Mar; 12(2):198-9. PubMed ID: 16476098
    [No Abstract]   [Full Text] [Related]  

  • 4. Dosage requirements for substitution therapy in hemophiliacs.
    Scand J Haematol Suppl; 1980; 35():29-54. PubMed ID: 6770459
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune tolerance by intermittent factor VIII boluses in two high responder hemophilia A patients.
    Landolfi R; de Cristofaro R; Lazzareschi I; Riccardi R; Mariani G
    Haematologica; 2000 Oct; 85(10 Suppl):73-4. PubMed ID: 11187877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of factor VIII in hemophilia A patients assessed by frequency response method.
    Durisová M; Dedík L; Bátorová A; Sakalová A; Hedera J
    Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):217-26. PubMed ID: 9646284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intensive substitution therapy of hemophilics].
    Weissbach G; Domula M; Lenk H
    Kinderarztl Prax; 1976 Aug; 44(8):360-7. PubMed ID: 966462
    [No Abstract]   [Full Text] [Related]  

  • 8. [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
    Ferencz T; Skopál J; Csáki C; Laczkó M; Schuler D; Borsi J
    Orv Hetil; 1993 Dec; 134(52):2873-5. PubMed ID: 8272354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience concerning substitution therapy of adult haemophiliacs in the Grisons (author's transl)].
    Hartmann S
    Ther Umsch; 1979 Apr; 36(4):301-6. PubMed ID: 451948
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience gained in 35 operations in patients with hemophilia A.
    Ziemski JM; Lopaciuk S; Rudowski W
    Pol Med J; 1971; 10(5):1269-77. PubMed ID: 5133676
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with prophylaxis in Sweden.
    Nilsson IM
    Semin Hematol; 1993 Jul; 30(3 Suppl 2):16-9. PubMed ID: 8367738
    [No Abstract]   [Full Text] [Related]  

  • 12. [Incidence of inhibitors in children with hemophilia A].
    Izquierdo-Ramírez J; Contreras-Mulato EL; Sotelo-Ham EI; Marín-Palomares T; Dueñas-González MT; Benítez-Aranda H
    Bol Med Hosp Infant Mex; 1988 Sep; 45(9):578-82. PubMed ID: 3142496
    [No Abstract]   [Full Text] [Related]  

  • 13. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic liver dysfunction in patients with hemophilia A. Effect of introduction of factor VIII concentrate].
    Kojima S; Tonouchi T; Ikegaya M; Mimaya J
    Rinsho Ketsueki; 1984 Jan; 25(1):31-6. PubMed ID: 6431147
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune tolerance in two high responder, severe hemophilia A patients with inhibitors: the importance of high doses and the duration of the treatment.
    Ciavarella N; Schiavoni M; Fasano A; Giliberti MG; Ettorre C; Stefanile C
    Vox Sang; 1996; 70 Suppl 1():72-3. PubMed ID: 8869475
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rehabilitation of children and young people with hemophilia].
    Ahlberg A
    Lakartidningen; 1968 Mar; 65(10):1026-8. PubMed ID: 5720698
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune tolerance therapy for haemophilia A patients with acquired factor VIII alloantibodies: comprehensive analysis of experience at a single institution.
    Smith MP; Spence KJ; Waters EL; Beresford-Webb R; Mitchell MJ; Cuttler J; Alhaq A; Brown SA; Savidge GF
    Thromb Haemost; 1999 Jan; 81(1):35-8. PubMed ID: 9974371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Substitution therapy in operations on hemophiliacs].
    Meili EO; Kaufmann L; Schneider W
    Ther Umsch; 1979 Apr; 36(4):307-10. PubMed ID: 451949
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate.
    Guérois C; Laurian Y; Rothschild C; Parquet-Gernez A; Duclos AM; Négrier C; Vicariot M; Fimbel B; Fressinaud E; Fiks-Sigaud M
    Thromb Haemost; 1995 Feb; 73(2):215-8. PubMed ID: 7792732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perioperative management of orthopaedic patients with hemophilia A].
    Wu YG; Li XG; Zhang KN; Ren YJ; Li SF; Lu MY
    Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(23):1430-3. PubMed ID: 15733456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.